Carmen Mecca

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Temporal Lobe Epilepsy

Top Venues

Disease markers

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob D Soumerai, Allison Rosenthal, Shannon K Harkins, Jessica Duffy, Carmen Mecca, Yingbing Wang, Ravinder K Grewal, Areej R El-Jawahri, Huiyun Liu, Cedric Menard, Ahmet Dogan, Lei Yang, Lisa M Rimsza, Kurt Bantilan, Haley Martin, Matthew M Lei, Sydney Mohr, Anna Kurilovich, Olga Mikhaylovna Plotnikova, Ekaterina Postovalova, Valentina Nardi, Jeremy S Abramson, Roberto Chiarle, Andrew D Zelenetz, Abner Louissaint
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma. Blood 140 (16) (2022)
Elif Karaca Atabay, Carmen Mecca, Qi Wang, Chiara Ambrogio, Ines Mota, Nina Prokoph, Giulia Mura, Cinzia Martinengo, Enrico Patrucco, Giulia Leonardi, Jessica Hossa, Achille Pich, Luca Mologni, Carlo B Gambacorti-Passerini, Laurence Brugieres, Birgit Geoerger, Suzanne D Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood (2021)
Carmela Conte, Cataldo Arcuri, Samuela Cataldi, Carmen Mecca, Michela Codini, Maria Rachele Ceccarini, Federica Filomena Patria, Tommaso Beccari, Elisabetta Albi
Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor. International journal of molecular sciences 20 (9) (2019)
Carmen Mecca, Ileana Giambanco, Rosario Donato, Cataldo Arcuri
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence. Disease markers 2018 (2018)